174 related articles for article (PubMed ID: 28585885)
1. Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study.
Cronin-Fenton DP; Kjærsgaard A; Ahern TP; Mele M; Ewertz M; Hamilton-Dutoit S; Christiansen PM; Ejlertsen B; Sørensen HT; Lash TL; Silliman RA
Acta Oncol; 2017 Sep; 56(9):1155-1160. PubMed ID: 28585885
[TBL] [Abstract][Full Text] [Related]
2. Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark.
Collin LJ; Cronin-Fenton DP; Ahern TP; Christiansen PM; Damkier P; Ejlertsen B; Hamilton-Dutoit S; Kjærsgaard A; Silliman RA; Sørensen HT; Lash TL
BMJ Open; 2018 Aug; 8(7):e021805. PubMed ID: 30068618
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
Yamashita H; Ogiya A; Shien T; Horimoto Y; Masuda N; Inao T; Osako T; Takahashi M; Endo Y; Hosoda M; Ishida N; Horii R; Yamazaki K; Miyoshi Y; Yasojima H; Tomioka N;
Breast Cancer; 2016 Nov; 23(6):830-843. PubMed ID: 26467036
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial.
Knoop AS; Lænkholm AV; Jensen MB; Nielsen KV; Andersen J; Nielsen D; Ejlertsen B;
Eur J Cancer; 2014 May; 50(8):1412-21. PubMed ID: 24675287
[TBL] [Abstract][Full Text] [Related]
5. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark.
Cronin-Fenton D; Kjærsgaard A; Nørgaard M; Amelio J; Liede A; Hernandez RK; Sørensen HT
Breast Cancer Res Treat; 2018 Jan; 167(2):517-528. PubMed ID: 28948396
[TBL] [Abstract][Full Text] [Related]
8. A validated algorithm for register-based identification of patients with recurrence of breast cancer-Based on Danish Breast Cancer Group (DBCG) data.
Aagaard Rasmussen L; Jensen H; Flytkjær Virgilsen L; Jellesmark Thorsen LB; Vrou Offersen B; Vedsted P
Cancer Epidemiol; 2019 Apr; 59():129-134. PubMed ID: 30743224
[TBL] [Abstract][Full Text] [Related]
9. Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration.
Ejlertsen B; Offersen BV; Overgaard J; Christiansen P; Jensen MB; Kroman N; Knoop AS; Mouridsen H
Acta Oncol; 2018 Jan; 57(1):3-12. PubMed ID: 29205077
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer.
Tramm T; Kyndi M; Myhre S; Nord S; Alsner J; Sørensen FB; Sørlie T; Overgaard J
Acta Oncol; 2014 Oct; 53(10):1337-46. PubMed ID: 24957550
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study.
Cronin-Fenton DP; Hellberg Y; Lauridsen KL; Ahern TP; Garne JP; Rosenberg C; Silliman RA; Sørensen HT; Lash TL; Hamilton-Dutoit S
Acta Oncol; 2012 Feb; 51(2):254-61. PubMed ID: 22129357
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
13. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
Jankowitz RC; McGuire KP; Davidson NE
Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
[TBL] [Abstract][Full Text] [Related]
14. Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort.
Lyngholm CD; Laurberg T; Alsner J; Damsgaard TE; Overgaard J; Christiansen PM
Acta Oncol; 2016 Aug; 55(8):983-92. PubMed ID: 27120011
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial].
Rose C; Andersen JA; Andersen KW; Axelsson CK; Blichert-Toft M; Dombernowsky P; Hansen M; Krag C; Mouridsen HT; Overgaard M
Ugeskr Laeger; 1991 Aug; 153(33):2283-7. PubMed ID: 1781047
[TBL] [Abstract][Full Text] [Related]
16. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
; Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
J Clin Oncol; 2006 May; 24(15):2268-75. PubMed ID: 16618947
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.
Inwald EC; Koller M; Klinkhammer-Schalke M; Zeman F; Hofstädter F; Lindberg P; Gerstenhauer M; Schüler S; Treeck O; Ortmann O
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2229-40. PubMed ID: 26253629
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
[TBL] [Abstract][Full Text] [Related]
19. Recurrence pattern and prognosis in low-risk breast cancer patients--data from the DBCG 89-A programme.
Christiansen P; Al-Suliman N; Bjerre K; Møller S;
Acta Oncol; 2008; 47(4):691-703. PubMed ID: 18465337
[TBL] [Abstract][Full Text] [Related]
20. The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016.
Jensen MB; Laenkholm AV; Offersen BV; Christiansen P; Kroman N; Mouridsen HT; Ejlertsen B
Acta Oncol; 2018 Jan; 57(1):13-18. PubMed ID: 29202621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
